The A3 adenosine receptor is highly expressed in tumor versus normal cells: Potential target for tumor growth inhibition

Clinical Cancer Research

Volumn 10, Issue 13, 2004, Pages 4472-4479

  Madi, Lea ^a   Ochaion, Avivit ^a   Rath Wolfson, Lea ^b   Bar Yehuda, Sara ^a   Erlanger, Abigail ^a   Ohana, Gil ^b   Harish, Arie ^b   Merimski, Ofer ^c   Barer, Faina ^a   Fishman, Pnina ^a  

^a Can Fite BioPharma Ltd   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A3 RECEPTOR; BETA ACTIN; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MELANOMA; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMALL CELL CARCINOMA; SOLID TUMOR; BIOSYNTHESIS; BREAST TUMOR; COLON TUMOR; DOWN REGULATION; LUNG TUMOR; METABOLISM; METASTASIS; NEOPLASM; PAGET NIPPLE DISEASE; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN D1; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B; RECEPTOR, ADENOSINE A3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 3042776794     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0651     Document Type: Article

References (19)

1. Schutle G, Fredholm BB. Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 2002;6:1137-46.
2. Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene 2002;21:4060-4.
3. Ohana G, Bar-Yehuda S, Arich A, et al. Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. Br J Cancer 2003;89:1552-8.
4. 3AR agonist. Anticancer Res 2003;23:2077-83.
5. Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, Fishman P. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. J Biol Chem 2003;278:42121-30.
6. Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AF, Pathak S, The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res 2001;269:230-6.
7. Ohana G, Bar-Yehuda S, Barer F, Fishman P. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J Cellular Physiol 2001;186:19-23.
8. Bar-Yehuda S, Madi L, Barak D, et al. Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents. Exp Hematol 2002;30:1390-8.
9. Gessi S, Varani K, Merighi S, et al. A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Br J Pharmacol 2001;134:116-26.
10. Merighi S, Varani K, Gessi S, et al. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Br J Pharmacol 2001;134:1215-26.
11. Suh BC, Kim TD, Lee JU, Seong JK, Kim KT. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Br J Pharmacol 2001;134:132-42.
12. Trincavelli ML, Tuscano D, Marroni M, et al. A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol Pharmacol 2002;62:1373-84.
13. 2B receptor. Mol Pharmacol 1997;52:846-60.
14. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996;118:1461-8.
15. Carre DA, Mitchell CH, Peterson-Yantorno K, Coca-Prados M, Civan MM. Similarity of A(3)-adenosine and swelling-activated Cl(-) channels in nonpigmented ciliary epithelial cells. Am J Physiol Cell Physiol 2000;279:C440-51.
16. Atkinson MR, Townsend-Nicholson A, Nicholl JK, Sutherland GR, Schofield PR. Activation of hippocampal adenosine A3 receptors produces a desensitization of Al receptor-mediated responses in rat hippocampus. Neurosci Res 1997;29:73-9.
17. Black RG Jr, Guo Y, Ge Z-D, et al. Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor Circ Res 2002;91:165-72.
18. Dougherty C, Barucha J, Schofield PR, Jacobson KA, Liang BT. Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor. FASEB J 1988;12:1785-92.
19. Dhalla AK, Shryock JC, Shreeniwas R, Belardinelli L. Pharmacology and therapeutic application of Al adenosine receptor ligands. Curr Top Med Chem 2003;3:369-85.